Clin2
NCT07456488Likely a fitRecruiting

Atropine eye drops for nearsighted children

Focus on Axial Length

Part of Eyes & vision clinical trials.

This study tests if low-dose atropine eye drops can slow down worsening nearsightedness in children. Children in the study receive either the drops or no treatment, and their vision changes are tracked over time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
4 years to 16 years
Study type
Interventional

Who can take part

  • Your child is between 4 and 16 years old.
  • They have nearsightedness of at least -1.00 diopters (a standard eye test measurement).
  • Their astigmatism (blur from an irregularly shaped cornea) is less than -2.50 diopters.
  • They haven't used atropine drops, pirenzipine, or contact lenses before.
  • They don't have certain health conditions like Marfan syndrome, Stickler syndrome, or a history of eye surgery.
  • They are not allergic to atropine.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07449247Not yet recruiting· Phase 1/Phase 2
Atropine eye drops for preventing nearsightedness in children

This study tests whether low-dose atropine eye drops can prevent nearsightedness (myopia) in children. Atropine is a medicine that has been used to slow myopia, and this trial looks at gradually increasing the dose to find the best approach.

NCT06389110Recruiting· Phase 3
Low-dose atropine drops to slow children's nearsightedness

This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.

Mexico City
NCT06708156Recruiting· Phase 3
Low-dose atropine drops to slow childhood nearsightedness

This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.

Hefei, Anhui
NCT07329777Recruiting· Phase 3
Atropine eye drops for children with worsening nearsightedness

This trial tests whether daily atropine eye drops can slow down worsening nearsightedness in children. It's for kids aged 5–10 whose myopia is actively progressing.

Kuala Lumpur, Cheras
NCT07164092Not yet recruiting· Phase 2/Phase 3
Atropine eye drops to slow myopia in children

This trial tests whether atropine eye drops can reduce the progression of myopia (nearsightedness, where you have trouble seeing far away) in children. It might help slow down the worsening of vision over time.

NCT04252989Recruiting
Atropine eye drops for slowing worsening nearsightedness in kids

This trial studies using low-dose atropine eye drops to help slow worsening nearsightedness (myopia) in children. It may help kids whose myopia is actively getting worse, depending on how consistently the drops are used.

Saint-Etienne

Hear when a new Focus on Axial Length trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.